We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

So much so that it even surpassed the Los Angeles Dodgers. According to Bob Nightengale of USA Today, he mentioned that the Mets $323.1 million payroll beats out the $321.3 million from the Dodgers.

Teams that fulfilled requests for government documents lost their jobs on Tuesday as part of the Trump administration's 10,000-person staff cuts at the Department of Health and Human Services. Their ...